Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, ...
As per Future Market Insights, PSG devices are expected to be the most preferred sleep apnea diagnostic systems during the ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
The American Heart Association says heart diseases are the leading cause of death in the US. Experts tell Digital Trends that ...
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.
The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...
You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate ...
Apple Watch users regularly credit the device with helping save their life during health scares and emergency situations. For ...